Evidence map›Paper›PMID 31315138›Full record

ArticleApplied clinical informatics2019

Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety.

Sara Ibáñez-Garcia, Carmen Rodriguez-Gonzalez, Vicente Escudero-Vilaplana, Maria Luisa Martin-Barbero, Belén Marzal-Alfaro, Jose Luis De la Rosa-Triviño, Irene Iglesias-Peinado, Ana Herranz-Alonso, Maria Sanjurjo Saez

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Applied clinical informatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sara Ibáñez-GarciaInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Carmen Rodriguez-GonzalezInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Vicente Escudero-VilaplanaInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Maria Luisa Martin-BarberoInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Belén Marzal-AlfaroInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Jose Luis De la Rosa-TriviñoYsengineers S.L., Málaga, Spain.
Irene Iglesias-PeinadoPharmacology Department, College of Pharmacy, Complutense University of Madrid, Madrid, Spain.
Ana Herranz-AlonsoInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Maria Sanjurjo SaezInstituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Hospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical decision support systems (CDSSs) are a good strategy for preventing medication errors and reducing the incidence and severity of adverse drug events (ADEs). However, these systems are not very effective and are subject to multiple limitations that prevent their implementation in clinical practice.

objectivesThe objective of this study was to evaluate the effectiveness of an advanced CDSS, HIGEA, which generates alerts based on predefined clinical rules to identify patients at risk of an ADE.

methodsA multidisciplinary team defined the system and the clinical rules focusing on medication errors commonly encountered in clinical practice. Four intervention programs were defined: (1) dose adjustment in renal impairment; (2) adjustment of anticoagulation/antiplatelet therapy; (3) detection of biochemical/hematologic toxicities; and (4) therapeutic drug monitoring. We performed a 6-month observational prospective study to analyze the effectiveness of these clinical rules by calculating the positive predictive value (PPV).

resultsThe team defined 211 clinical rules. During the study period, HIGEA generated 1,086 alerts (8.9 alerts per working day), which were reviewed by pharmacists. Fifty-one percent (554/1,086) of alerts generated an intervention to prevent a possible ADE; of these, 66% (368/554) required a documented modification to therapy owing to a real prescription error intercepted. The intervention program that induced the highest number of modifications to therapy was the dose adjustment in renal impairment program (PPV = 0.51), followed by the adjustment of anticoagulation/antiplatelet therapy program (PPV = 0.24). The percentage of accepted interventions was similar in surgical units (68%), medical units (67%), and critical care units (63%).

conclusionOur study offers evidence that HIGEA is highly effective in preventing potential ADEs at the prescription stage.

Indexed as

Decision Support Systems, ClinicalPatient SafetyHumansMedical Order Entry SystemsMedication Errors

Identifiers

PMID31315138
PMCPMC6637024
OpenAlexW2960195478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.